Amedisys (AMED) PT Cut to $47 at Mizuho Following Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Amedisys Reports Third Quarter Financial Results
November 3, 2016 5:15 PM EDTBATON ROUGE, La., Nov. 03, 2016 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading home health and hospice company, today reported its financial results for the three and nine-month periods ended September 30, 2016.
Three-Month Periods Ended September 30, 2016 and 2015
Net service revenue increased $35.2 million to $361.6 million compared to $326.4 million in 2015.Net income attributable to Amedisys, Inc. of $11.4 million compared to $8.4 million in 2015.Net income attributable to Amedisys, Inc. per diluted share of $0.34 per diluted share compared to $0.25 in 2015.... More


